Avnet, Inc. (AVT)

The Take — Sell the peak. The market is capitalizing a memory-price boom as if it were the new normal.

This is the textbook cyclical-peak trap the screen was built to catch. Avnet looks cheap on every trailing and forward multiple — ~8x the Q1-FY27 guided run-rate EPS ($2.85×4 = $11.40), PEG <1, "accelerating" revenue (+48% y/y in the June quarter, Q1 guide $9.0–9.3B). But sales are running ~$-99% above the 10-year trend line ($27.7B trend vs ~$36B run-rate), and management itself says about one-third of the growth is memory pricing with OEMs building safety stock and lead times stretching. That is the exact signature of FY18, FY22–23: double-ordering into price inflation, followed by an inventory correction (FY20 sales −10%, FY23→FY25 −16%, adjusted margin 4.6% → 2.8%).

Normalize and the value collapses to roughly book. Ten fiscal years of adjusted operating margin average 3.28% (range 1.7%–4.6%). Avnet has booked restructuring every single year (avg $91M; 0.29% of sales over the last five) — that is a recurring cost of doing business, so normalized EBIT is 2.98%. On that margin, after-tax ROIC is ~7.6% against a 9.6% WACC: through the cycle this business earns slightly less than its cost of capital, so it should trade near invested capital, not at a premium. Base case — the upcycle runs through FY28 (FY27 sales $35.5B at 3.8% EBIT), then a −13% FY29 correction that releases ~$1.1B of working capital, then trend growth at normalized margins — is worth $56.05. Book value is ~$61/share.

The reverse DCF is the whole argument: $95 requires a 4.5% EBIT margin forever (above the FY23 all-time-cycle high of 4.6% adjusted, before restructuring) or a 7.0% WACC with a 5.2% risk-free rate. Our "supercycle" case — no correction at all, sales compounding from $36B, 4.0% EBIT forever — gets ~$101. You are paying today for the cycle never turning.

What's changed vs the Sep-4 build ($79): Rf 4.25% → 5.20% costs ~$9/share; charging recurring restructuring costs ~$9; the bigger upcycle adds a few dollars of near-term cash. Same discipline, harsher rate regime. Leverage also matters here: gross debt $3.2B (3.2x gross leverage) with $251M/yr interest, and FY26 operating cash flow was −$281M — the boom is consuming cash, not producing it, until the cycle rolls and working capital comes home.

Call: TRIM / AVOID. No new money above ~$65 (base + ~15%). Value accumulation zone ≤$55 (≈ base, ~0.9x book) — historically where AVT trades after a correction (52-wk low $44). Holders: sell into strength; the stock printed $108.63 on Oct 2. Defined-risk bearish expression: after the Q1-FY27 print (late Oct; date not yet confirmed), a 30–45 DTE bear call spread with the short strike above the $108–110 high. Do not short outright into the print — Q1 guide implies EPS growth >200% y/y and momentum names can gap +10% on a beat-and-raise. Kill the bearish view if Q2 guide shows sales growth without further working-capital build (i.e., real unit demand, not price + safety stock).